Snapshots from the Edge: Expert Insights into How AI is Shaping Personalized Cancer Treatment

“All diseases are in evolution, and what we really should be doing is monitoring patients over time. Do you have a rapidly metastasising cancer, or do you have one that’s just quite slowly growing? The rate of change of a patient should be built into these AI models, because it might adjust the treatment course for any given individual.”

Allison Morgan Managing Director at Metis Clinical, and Jan Wolber, Product Leader, Digital at GE HealthCare Pharmaceutical Diagnostics, discuss the potential requirement for diagnostic and treatment pathways to be refined alongside AI-DDS models.